Evidence map›Paper›PMID 35594492›Full record

ReviewJCO global oncology2022

Impact of COVID-19 Disease in Early Breast Cancer Management: A Summary of the Current Evidence.

Francisco Pimentel Cavalcante, Edson Abdala, Leonardo Weissmann, Carlos Eduardo Dos Santos Ferreira, Gilberto Amorim, Vilmar Marques de Oliveira, Gisah Guilgen, Luciana Landeiro, João Renato Rebello Pinho, Álvaro Pulchinelli and 3 more

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in JCO global oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 1 country.

Francisco Pimentel CavalcanteFortaleza General Hospital (HGF), Fortaleza, CE, Brazil.ORCID 0000-0002-7156-2890
Edson AbdalaDepartment of Infectious and Parasitic Diseases, School of Medicine, University of São Paulo (USP), São Paulo, SP, Brazil.ORCID 0000-0003-0765-6654
Leonardo WeissmannEmílio Ribas Infectious Disease Institute, São Paulo, SP, Brazil.ORCID 0000-0002-4702-3221
Carlos Eduardo Dos Santos FerreiraAlbert Einstein Hospital, São Paulo, SP, Brazil.
Gilberto AmorimOncologia D'Or, Rio de Janeiro, RJ, Brazil.ORCID 0000-0002-3076-2378
Vilmar Marques de OliveiraBrazilian Society of Mastology, Rio de Janeiro, RJ, Brazil.ORCID 0000-0002-9478-5616
Gisah GuilgenBrazilian Breast Cancer Study Group (GBECAM), Porto Alegre, RS, Brazil.ORCID 0000-0001-8048-8381
Luciana LandeiroNúcleo de Oncologia da Bahia (NOB)-Oncoclínicas Group, Salvador, BA, Brazil.ORCID 0000-0002-9021-5229
João Renato Rebello PinhoAlbert Einstein Hospital, São Paulo, SP, Brazil.ORCID 0000-0003-3999-0489
Álvaro PulchinelliBrazilian Society of Clinical Pathology/Laboratory Medicine, Rio de Janeiro, RJ, Brazil.
Heber RibeiroBrazilian Society of Oncology Surgery, Rio de Janeiro, RJ, Brazil.ORCID 0000-0002-3412-7451
Rafael SouzaCancer Treatment Institute (ITC), Campo Grande, MS, Brazil.ORCID 0000-0002-5948-2185
Daniela Dornelles RosaBrazilian Breast Cancer Study Group (GBECAM), Porto Alegre, RS, Brazil.
Universidade de São Paulo · BRAC Camargo Hospital · BRCentro Universitário Curitiba · BRD’Or Institute for Research and Education · BRFleury S.A. (Brazil) · BRHospital Geral de Fortaleza · BRHospital Israelita Albert Einstein · BRInstituto de Infectologia Emílio Ribas · BRSanta Casa Hospital · BRUniversidade Federal de Ciências da Saúde de Porto Alegre · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAn expert panel on breast cancer and COVID-19 disease was convened to address the impact of the COVID-19 pandemic for early breast cancer (eBC) management.

methodsTo ensure that the most clinically relevant information was addressed, essential information was drawn from several of the latest national and international guidelines and another technical document. The expert panel met in five virtual closed sessions from November 2020 to May 2021 to consult on the relevant data from evidence-based results. The data gathered were discussed on an online platform.

resultsThis article reports the expert panel's highlights of these meetings' discussions. In addition, it provides practical recommendations covering topics regarding diagnosis, treatment, and management of patients with eBC in clinical settings routinely encountered by health care professionals amid the COVID-19 pandemic.

conclusionThis article provided guidance on several topics regarding eBC management amid the COVID-19 pandemics to inform safer care practices.

Indexed as

Breast NeoplasmsCOVID-19FemaleHumansPandemics

Identifiers

PMID35594492
PMCPMC9173577
OpenAlexW4281257987

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.